Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | ADK | P55263 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | TYMP | P19971 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.34 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4723685 | 0.77 | ABCG2 (0.43) | KDM4EGAAGSK3BADKALDH1A1 | |
| SCHEMBL16322764 | 0.74 | HSD17B10 (0.47) | KDM4EGSK3BALDH1A1ALOX15PTPN1 | |
| SCHEMBL1257288 | 0.73 | RAB9A (0.52) | KDM4EGAAGSK3BALDH1A1ALOX15 | |
| SCHEMBL5750914 | 0.73 | KDM4E (0.45) | BCHEKDM4EALDH1A1CYP2A6HSD17B10 | |
| SCHEMBL718222 | 0.72 | ALDH1A1 (0.41) | KDM4EALPLGAAALDH1A1TSHR | |
| SCHEMBL6609359 | 0.72 | ALDH1A1 (0.38) | GAAALDH1A1TSHRTDP1 | |
| SCHEMBL7781750 | 0.71 | HTR2B (0.42) | NISCHCYP1A2 | |
| SCHEMBL7186438 | 0.71 | ATM (0.32) | ADKALDH1A1CYP2A6KIF11HSD17B10 | |
| SCHEMBL4508938 | 0.71 | MAOB (0.59) | KDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL646330 | 0.70 | ALDH1A1 (0.42) | KDM4EALPLGAAALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070027158-A1 | High affinity small molecule C5a receptor modulators | NEUROGEN CORPORATION | 2007-02-01 | — | — | US | claimed |
| US-5624939-A | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders | RHONE-POULENC RORER, S.A. (FR) | 1997-04-29 | — | — | US | claimed |
| US-20070092488-A1 | Methods of treating idiopathic pulmonary fibrosis | INTERMUNE INC. (US) | 2007-04-26 | — | — | US | disclosed |
| US-6545152-B1 | Viricides; polymerase enzyme inhibitor | PARKER HUGHES INSTITUTE | 2003-04-08 | — | — | US | disclosed |
| US-3997584-A | Substituted glycines and intermediates thereof | SMITHKLINE CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027158-A1 | High affinity small molecule C5a receptor modulators | C3AR1, C5AR1, C5AR2 | BCHE 1835/4885KDM4E 3927/4885ALPL 4647/4885 |
| US-20070092488-A1 | Methods of treating idiopathic pulmonary fibrosis | IFNG, MMP1, IFNAR1 | BCHE 2789/4885KDM4E 4367/4885ALPL 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.